• USFDA seeks voluntary action at Dr Reddy’s Duvvada facility

    • February 17, 2020
    • Posted By : Peeyush Jaiswal
    • 0 Comment
    •   12 views

    The US health regulator has asked drug major Dr Reddy’s Laboratories to initiate voluntary action at its Duvvada facility in Andhra Pradesh.

    “With regard to the audit of our Formulations Manufacturing Plant at Duvvada, Visakhapatnam, we would like to inform you that we have been notified by the United States Food and Drug Administration (USFDA), that the inspection classification of the above-referred facility is determined as Voluntary Action Initiated,” Dr Reddy’s Laboratories on Sunday said in a BSE filing.

    Shares of Dr Reddy’s Laboratories on Friday closed at Rs 3,307.50 apiece, down 0.55 percent on the BSE.

  12 views

You Might Also Like

No comments found

LEAVE COMMENT

Archive

Offers
error: Content is protected !!